Lochi Bio

Lochi Bio is a biotechnology company pioneering the field of subcellular RNA localization to create a new class of precision medicines. The company's platform technology enables the engineering of RNA molecules that can be directed to specific locations within a cell, ensuring that therapeutic proteins are produced exactly where they are needed. This spatial control aims to maximize therapeutic efficacy while minimizing systemic toxicity and off-target effects. Currently in the pre-clinical stage, Lochi Bio is applying its platform to address complex diseases in oncology and neurology that have remained challenging for conventional RNA therapies. The company's approach represents a significant shift from traditional mRNA medicine by adding a spatial dimension to genetic instruction.